Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 20;13(5):455-464.
doi: 10.1007/s13770-016-9093-2. eCollection 2016 Oct.

The therapeutic potential of stem cells and progenitor cells for the treatment of Parkinson's disease

Mooi Tiong Liau  1 , Farahnaz Amini  1 , Thamil Selvee Ramasamy  2
Affiliations

The therapeutic potential of stem cells and progenitor cells for the treatment of Parkinson's disease

Mooi Tiong Liau et al. Tissue Eng Regen Med. .

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is usually seen in those above 50 years old. Current medical treatments only provide symptomatic relief but cannot cure the disease. There are claims that PD can be cured by stem cell transplant. The present study is aimed to assess the clinical potency and safety of stem cell in treating PD. A total of eleven articles were included for analysis, with four randomised control trials (RCTs), five non-RCTs and 2 follow up studies. All the four non-RCTs showed improvement of Unified Parkinson's Disease Rating Scale with no adverse events. However, results from RCTs showed no significant differences in the rating score among the transplant group and the Sham surgery group. The secondary analysis of one study showed a significant improvement of the rating score in those patients aged 60 and younger. Transplant group also associated with an overall higher incidence of adverse events. In conclusion, the RCTs and non-RCTs produced opposite results. When the studies were performed as non-RCTs in small number of patients, they showed promising result in the patients. It could say that currently the use of stem cell/progenitor cells in treating PD need much research despite having the implanted stem cell to be able to survive and integrated. The survival of implanted dopamine neurons in the striatum, however, does not indicate a success in correcting PD symptoms. Further investigations will shed light on the application and mechanism of action of stem cells in treating PD.

Electronic supplementary material: Supplementary material is available for this article at 10.1007/s13770-016-9093-2 and is accessible for authorized users.

Keywords: Cell therapy; Neuro-regeneration and neuroprotection; Neurodegenerative disease; Stem cell transplantation.

PubMed Disclaimer

References

    1. Gale E, Li M. Midbrain dopaminergic neuron fate specification:of mice and embryonic stem cells. Mol Brain. 2008;1:8. doi: 10.1186/1756-6606-1-8. - DOI - PMC - PubMed
    1. Kumar P, Clark M. Clinical Medicine:a text book for medical students and doctors. 1994.
    1. Parkinson’s Disease. [Internet] 2012 May [cited 2013 July 13]. Available from:http://www.stemcellnetwork.ca/en/diseases/parkinsons-disease/.
    1. Tan LC, Venketasubramanian N, Jamora RD, Heng D. Incidence of Parkinson’s disease in Singapore. Parkinsonism Relat Disord. 2007;13:40–43. doi: 10.1016/j.parkreldis.2006.07.003. - DOI - PubMed
    1. Chew NK, Goh KJ, Tan CT. Parkinson’s disease in university hospital, Kuala Lumpur. Neurol J Southeast Asia. 1998;3:75–80.